In the present study, we investigated the relationship between MAPK/ERK signaling pathway and SHH signaling pathway in RA-FLSs, and found that Purmorphamine could increase the expression of p-ERK1/2 protein in concentration-and time-dependent manners. This evidence concerns the gene MAPK3 and rheumatoid arthritis.